Neuroendocrine Cancers (NETs and NECs) are globally increasing in incidence (those newly diagnosed) and prevalence (those living with Neuroendocrine Cancer). However, many may not be diagnosed until liver metastases (spread) has occurred. Neuroendocrine liver...
Have you heard our latest podcast episode?
In this latest episode of the Not Just NE Cancer podcast, Neuroendocrine Cancer UK CEO and Co-Founder, Cathy Bouvier Ellis sits down with Tanya Hills, Global Patient Engagement Lead at Boehringer Ingelheim. CLICK HERE to listen today!
